S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01

Cognyte Software Stock Forecast, Price & News

-0.73 (-5.32%)
(As of 01/14/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
1.00 million shs
Average Volume
1.10 million shs
Market Capitalization
$856.55 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive CGNT News and Ratings via Email

Sign-up to receive the latest news and ratings for Cognyte Software and its competitors with MarketBeat's FREE daily newsletter.

Cognyte Software logo

About Cognyte Software

Cognyte Software Ltd. provides security analytics software to governments and enterprises worldwide. The company's open software fuses, analyzes, and visualizes disparate data sets for security organizations. It offers investigative analytics, operational intelligence analytics, and threat intelligence analytics solutions. The company's end-users for its solutions include data analysts, investigation managers, security operating centers operators, and field unit teams. It also provides customer support, professional, and integration services. The company serves national, regional, and local government agencies; and enterprise customers consist of commercial and physical security customers. The company was incorporated in 2020 and is headquartered in Herzliya, Israel.


See More Headlines

Industry, Sector and Symbol

Prepackaged software
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$443.46 million
Cash Flow
$1.38 per share
Book Value
$4.11 per share


Net Income
$14.20 million
Pretax Margin




Free Float
Market Cap
$856.55 million
Not Optionable

Company Calendar

Last Earnings
Fiscal Year End


Overall MarketRank

2.52 out of 5 stars

Computer And Technology Sector

146th out of 888 stocks

Prepackaged Software Industry

38th out of 282 stocks

Analyst Opinion: 3.4Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 1.9 5 -4 -3 -2 -1 -

Cognyte Software (NASDAQ:CGNT) Frequently Asked Questions

Is Cognyte Software a buy right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cognyte Software in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Cognyte Software stock.
View analyst ratings for Cognyte Software
or view top-rated stocks.

How were Cognyte Software's earnings last quarter?

Cognyte Software Ltd. (NASDAQ:CGNT) posted its quarterly earnings data on Monday, December, 20th. The medical device company reported $0.21 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.10 by $0.11. The medical device company earned $118.70 million during the quarter, compared to analysts' expectations of $114.83 million. Cognyte Software had a trailing twelve-month return on equity of 10.53% and a net margin of 0.40%. The company's revenue for the quarter was up 5.0% on a year-over-year basis.
View Cognyte Software's earnings history

What guidance has Cognyte Software issued on next quarter's earnings?

Cognyte Software issued an update on its FY22 earnings guidance on Tuesday, December, 21st. The company provided earnings per share guidance of $0.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.81. The company issued revenue guidance of $470.4-$489.6 million, compared to the consensus revenue estimate of $489.74 million.

What price target have analysts set for CGNT?

5 brokers have issued 12-month price objectives for Cognyte Software's shares. Their forecasts range from $17.00 to $42.00. On average, they expect Cognyte Software's share price to reach $25.47 in the next twelve months. This suggests a possible upside of 96.2% from the stock's current price.
View analysts' price targets for Cognyte Software
or view top-rated stocks among Wall Street analysts.

Who are Cognyte Software's key executives?

Cognyte Software's management team includes the following people:
  • Mr. Elad Sharon, CEO & Director (Age 45)
  • Mr. David Abadi, Chief Financial Officer (Age 47)
  • Mr. Ziv Levi, Chief Legal Officer (Age 52)
  • Ms. Amit Daniel, Chief Marketing Officer (Age 49)
  • Ms. Rini Karlin, Chief People Officer (Age 49)
  • Mr. Miki Migdal, Chief Bus. Officer (Age 60)
  • Mr. Marom Ben Menahem, Chief Revenue Officer (Age 50)
  • Mr. Sharon Chouli, Chief Customer Officer (Age 51)

What other stocks do shareholders of Cognyte Software own?

What is Cognyte Software's stock symbol?

Cognyte Software trades on the NASDAQ under the ticker symbol "CGNT."

Who are Cognyte Software's major shareholders?

Cognyte Software's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Poehling Capital Management LLC (0.05%).
View institutional ownership trends for Cognyte Software

Which major investors are selling Cognyte Software stock?

CGNT stock was sold by a variety of institutional investors in the last quarter, including Poehling Capital Management LLC.
View insider buying and selling activity for Cognyte Software
or view top insider-selling stocks.

How do I buy shares of Cognyte Software?

Shares of CGNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cognyte Software's stock price today?

One share of CGNT stock can currently be purchased for approximately $12.98.

How much money does Cognyte Software make?

Cognyte Software has a market capitalization of $856.55 million and generates $443.46 million in revenue each year. The medical device company earns $14.20 million in net income (profit) each year or $0.03 on an earnings per share basis.

How many employees does Cognyte Software have?

Cognyte Software employs 2,000 workers across the globe.

What is Cognyte Software's official website?

The official website for Cognyte Software is www.cogentixmedical.com.

Where are Cognyte Software's headquarters?

Cognyte Software is headquartered at 5420 FELTL ROAD, MINNETONKA MN, 55343.

How can I contact Cognyte Software?

Cognyte Software's mailing address is 5420 FELTL ROAD, MINNETONKA MN, 55343. The medical device company can be reached via phone at 972-9962-2300 or via email at [email protected].

This page was last updated on 1/16/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.